506 related articles for article (PubMed ID: 11709358)
21. Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
Ahuja M; Singh I; Lavania M; Pathak VK; Darlong J; Turankar RP; Hembrom S; Singh SV; Sengupta U
J Glob Antimicrob Resist; 2022 Sep; 30():282-285. PubMed ID: 35717020
[TBL] [Abstract][Full Text] [Related]
22. Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.
Cambau E; Bonnafous P; Perani E; Sougakoff W; Ji B; Jarlier V
Clin Infect Dis; 2002 Jan; 34(1):39-45. PubMed ID: 11731943
[TBL] [Abstract][Full Text] [Related]
23. The chemotherapy of leprosy. Part 2.
Ellard GA
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):82-94. PubMed ID: 2030319
[No Abstract] [Full Text] [Related]
24. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Dhople AM; Dimova V
Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
[TBL] [Abstract][Full Text] [Related]
25. Molecular detection of drug resistance in Mycobacterium leprae.
Williams DL; Gillis TP
Lepr Rev; 2004 Jun; 75(2):118-30. PubMed ID: 15282962
[No Abstract] [Full Text] [Related]
26. Multiple mutations in the rpoB gene of Mycobacterium leprae strains from leprosy patients in Thailand.
Ramasoota P; Wongwit W; Sampunachot P; Unnarat K; Ngamying M; Svenson SB
Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):493-7. PubMed ID: 11289008
[TBL] [Abstract][Full Text] [Related]
27. A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae.
Honoré N; Perrani E; Telenti A; Grosset J; Cole ST
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):600-4. PubMed ID: 8151192
[TBL] [Abstract][Full Text] [Related]
28. Search for effective short-course regimens for the treatment of leprosy.
Pattyn SR
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
[No Abstract] [Full Text] [Related]
29. [Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries].
Matsuoka M; Suzuki Y; Makino M
Nihon Hansenbyo Gakkai Zasshi; 2010 Sep; 79(3):257-61. PubMed ID: 20857655
[TBL] [Abstract][Full Text] [Related]
30. Single-dose treatment for paucibacillary leprosy; field implications.
Revankar CR; Pai VV; Samy MS; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
[No Abstract] [Full Text] [Related]
31. The activity of rifabutin against Mycobacterium leprae.
Yoder LJ; Jacobson RR; Hastings RC
Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
[TBL] [Abstract][Full Text] [Related]
32. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
[No Abstract] [Full Text] [Related]
33. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
[TBL] [Abstract][Full Text] [Related]
34. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
35. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
36. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Dhople AM; Ibanez MA
Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
Andrade ESN; Brandão JG; Silva JSD; Coriolano CRF; Rosa PS; Moraes MO; Ferreira CO; Gomes CM; Araújo WN
Antimicrob Agents Chemother; 2022 May; 66(5):e0217021. PubMed ID: 35435708
[TBL] [Abstract][Full Text] [Related]
38. [DNA microarray based rapid drug susceptibility test for Mycobacterium leprae].
Suzuki Y; Matsuoka M
Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):271-7. PubMed ID: 17037383
[TBL] [Abstract][Full Text] [Related]
39. Transmission of Drug-Resistant Leprosy in Guinea-Conakry Detected Using Molecular Epidemiological Approaches.
Avanzi C; Busso P; Benjak A; Loiseau C; Fomba A; Doumbia G; Camara I; Lamou A; Sock G; Drame T; Kodio M; Sakho F; Sow SO; Cole ST; Johnson RC
Clin Infect Dis; 2016 Dec; 63(11):1482-1484. PubMed ID: 27558568
[TBL] [Abstract][Full Text] [Related]
40. Detection of gene mutations related with drug resistance in Mycobacterium leprae from leprosy patients using Touch-Down (TD) PCR.
Kim SK; Lee SB; Kang TJ; Chae GT
FEMS Immunol Med Microbiol; 2003 May; 36(1-2):27-32. PubMed ID: 12727362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
